View submitted responses where consent has been given to publish the response.
Published in 2000, Australia’s National Medicines Policy (NMP) aims to deliver positive health outcomes for all Australians through their access to and appropriate use of medicines. It is a well-established and universally endorsed framework based on partnerships between consumers and all segments of the medicines sector to promote the NMP’s four central objectives.
These are:
The Review of the NMP has been commissioned by the Minister for Health, the Hon. Greg Hunt MP in recognition of the substantial changes to the health landscape since the policy was published in 2000.
The Minister has established an Expert Advisory Committee to lead the Review of the NMP for the Department of Health. The Committee is chaired by Deputy Chief Medical Officer, Professor Michael Kidd AM. Its members include Professor Lloyd Sansom AO; Mrs Janette Donovan; Dr Sarah Dineen-Griffin and Mr David Herd.
This Review will support a refresh of the NMP as a high-level policy framework, to ensure that the changes in the health system environment are addressed, and where applicable, the policy updated to take account of these changes.
Terms of Reference
This is a high level review aimed at identifying any gaps in the NMP’s objectives, partnership approach and accountabilities. The Review of the NMP will:
A PDF version of the Review's Terms of Reference can be accessed here: Review of the National Medicines Policy - Terms of Reference.
Consultation Information
To gain insights from stakeholders, the Review Committee has prepared a Discussion Paper to support the consultation process. This Discussion Paper provides context for the Review and is intended to encourage consideration of the issues the Review could address.
Stakeholders are invited to participate in the consultation by responding to the questions within the Discussion Paper via the Consultation Survey. You may wish to respond to all or some of the questions.
Alternatively, the full Discussion Paper is available for download as a PDF here: Review of the National Medicines Policy - Discussion Paper. A response document can be uploaded on the final page.
Consultation is now open and will close on Friday 8 October 2021.
The primary purpose of this consultation process is to provide the Review Committee with an appreciation of the breadth of stakeholders' views, to support a refresh of the NMP. The Review’s Terms of Reference address areas that will support this refresh as a high-level policy framework, rather than reviewing the activities and programs aimed at delivering the policy.
The Committee would like to thank all stakeholders who have taken the time to provide a submission. The consultation process will continue throughout October and November 2021. This includes a program of meetings with key stakeholders, in addition to virtual group discussions.
Share
Share on Twitter Share on Facebook